SCHEMBL1042269

SCHEMBL1042269

C1=CC(c2ccccc2)(N(c2ccccc2)c2cccc3ccccc23)C=CC1c1ccc(N(c2ccccc2)c2cccc3ccccc23)cc1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17600568 0.97 SIGMAR1 (0.30) SIGMAR1
SCHEMBL2909286 0.90
SCHEMBL1042525 0.90
SCHEMBL9170581 0.88 CYP1A2 (0.32)
SCHEMBL4602835 0.80
SCHEMBL419796 0.77 SIGMAR1 (0.38) SIGMAR1
SCHEMBL21500413 0.76 SIGMAR1 (0.35) SIGMAR1
SCHEMBL4893902 0.73 SIGMAR1 (0.50) SIGMAR1
SCHEMBL4580501 0.73 SIGMAR1 (0.50) SIGMAR1
SCHEMBL2362015 0.73 SIGMAR1 (0.50) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675931-A1 ELECTROLUMINESCENT DEVICE WITH ANTHRACENE DERIVATIVE HOST EASTMAN KODAK COMPANY (US) 2006-07-05 EP claimed
WO-2005042668-A1 ELECTROLUMINESCENT DEVICE WITH ANTHRACENE DERIVATIVE HOST EASTMAN KODAK COMPANY (US) 2005-05-12 WO claimed
US-20050089717-A1 Electroluminescent device with anthracene derivative host EASTMAN KODAK COMPANY 2005-04-28 US claimed
US-11903243-B2 Optical film LG CHEM, LTD. (KR) 2024-02-13 US disclosed
EP-3719546-B1 OPTICAL FILM LG CHEMICAL LTD (KR) 2023-08-16 EP disclosed
EP-2871688-B1 SUBSTRATE FOR ORGANIC ELECTRONIC DEVICE LG CHEMICAL LTD (KR) 2022-09-21 EP disclosed
US-20210167334-A1 OPTICAL FILM LG CHEM, LTD. (KR) 2021-06-03 US disclosed
EP-2882006-B1 SUBSTRATE FOR ORGANIC ELECTRONIC DEVICE LG CHEMICAL LTD (KR) 2021-05-19 EP disclosed
US-10934262-B2 Heterocyclic bridged biphenyls UDC IRELAND LIMITED (IE) 2021-03-02 US disclosed
EP-3719546-A1 OPTICAL FILM LG CHEM, LTD. (KR) 2020-10-07 EP disclosed
EP-3147311-B1 PLASTIC SUBSTRATE LG CHEMICAL LTD (KR) 2020-05-27 EP disclosed
US-20050123791-A1 Organic electroluminescent devices EASTMAN KODAK COMPANY 2005-06-09 US disclosed
WO-2005042668-A1 ELECTROLUMINESCENT DEVICE WITH ANTHRACENE DERIVATIVE HOST EASTMAN KODAK COMPANY (US) 2005-05-12 WO disclosed
US-20050089717-A1 Electroluminescent device with anthracene derivative host EASTMAN KODAK COMPANY 2005-04-28 US disclosed
US-6885026-B1 Organic element for electroluminescent devices EASTMAN KODAK COMPANY (US) 2005-04-26 US disclosed
US-6875524-B2 White light-emitting device with improved doping EASTMAN KODAK COMPANY (US) 2005-04-05 US disclosed
US-20050048311-A1 WHITE LIGHT-EMITTING DEVICE WITH IMPROVED DOPING EASTMAN KODAK COMPANY 2005-03-03 US disclosed
US-6824895-B1 NEW ORGANOMETALLIC COMPOUNDS THAT WILL FUNCTION AS PHOSPHORESCENT MATERIALS HAVING USEFUL LIGHT EMISSIONS EASTMAN KODAK COMPANY 2004-11-30 US disclosed
US-20040223525-A1 VERTICAL CAVITY LASER INCLUDING INORGANIC SPACER LAYERS EASTMAN KODAK COMPANY 2004-11-11 US disclosed
US-20040070332-A1 Method of designing an OLED display with lifetime optimized primaries EASTMAN KODAK COMPANY 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934262-B2 Heterocyclic bridged biphenyls BMP2, BPTF, BMP4 SIGMAR1 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.